Melissa Myland

The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink

J.C. Kingswood, Pamela Crawford, Simon R. Johnson et al. · Journal of Medical Economics · 2016 · 32 citations · Full text

Pharmacy, Pediatrics, Pharmacoeconomics +17

Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD)

Charles Shepherd, Matthias J. Koepp, Melissa Myland et al. · BMJ Open · 2017 · 26 citations · Full text

Medicine, Neurology, Pharmacoeconomics +17

The economic burden of tuberous sclerosis complex in UK patients with renal manifestations: a retrospective cohort study in the clinical practice research datalink (CPRD)

J.C. Kingswood, Paola Nasuti, Keyur Patel et al. · Journal of Medical Economics · 2016 · 24 citations · Full text

Medicine, Nephrology, Pediatrics +17

Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom

Michael Feher, G. Vega-Hernández, Emina Mocevic et al. · Diabetes Therapy · 2017 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre

Chris Twelves, Sue Cheeseman, Will Sopwith et al. · BMC Cancer · 2020 · 21 citations · Full text

Medicine, Endocrinology, Oncology +17